The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Drug‐Nutrient Interactions
Abstract
Drug‐nutrient interactions are defined as physical, chemical, physiologic, or pathophysiologic relationships between a drug and a nutrient. The causes of most clinically significant drug‐nutrient interactions are usually multifactorial. Failure to identify and properly manage drug‐nutrient interactions can lead to very serious consequences and have a negative impact on patient outcomes. Nevertheless, with thorough review and assessment of the patient's history and treatment regimens and a carefully executed management strategy, adverse events associated with drug‐nutrient interactions can be prevented. Based on the physiologic sequence of events after a drug or a nutrient has entered the body and the mechanism of interactions, drug‐nutrient interactions can be categorized into 4 main types. Each type of interaction can be managed using similar strategies. The existing data that guide the clinical management of most drug‐nutrient interactions are mostly anecdotal experience, uncontrolled observations, and opinions, whereas the science in understanding the mechanism of drug‐nutrient interactions remains limited. The challenge for researchers and clinicians is to increase both basic and higher level clinical research in this field to bridge the gap between the science and practice. The research should aim to establish a better understanding of the function, regulation, and substrate specificity of the nutrient‐related enzymes and transport proteins present in the gastrointestinal tract, as well as assess how the incidence and management of drug‐nutrient interactions can be affected by sex, ethnicity, environmental factors, and genetic polymorphisms. This knowledge can help us develop a true personalized medicine approach in the prevention and management of drug‐nutrient interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, interactions between drugs and nutrients may result in a compromised nutritional status [62, 63].”
From The Use of Medications and Dietary Supplements by Masters Athletes—A Review (2022) · cites this paper as [62]
In the citing paper
“An interaction between a prescribed medication and a DS ingredient (herb or nutrient) can occur due to an alteration in the pharmacokinetic mechanisms and/or pharmacodynamic properties caused by concurrent intake [62].”
From The Use of Medications and Dietary Supplements by Masters Athletes—A Review (2022) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
H + ‐coupled nutrient, micronutrient and drug transporters in the mammalian small intestine
Thwaites, D. T., & Anderson, C. M. H. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2005.029959 · Cited by 188
Drug–Nutrient Interactions: A Broad View with Implications for Practice
Boullata, J. I., & Hudson, L. M. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jada.2011.09.002 · Cited by 138
Menon, B., & Harinarayan, C. V. (2010) · Seizure · doi:10.1016/j.seizure.2010.01.006 · Cited by 70
Sai, Y. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.91 · Cited by 60
Research works printed but not linked: 54
- 10.1111/j.1365-2125.2010.03722.x · DOI
- 10.1097/MPG.0b013e3181eb5ad6 · DOI
- Chan L‐N, 2013, Modern Nutrition in Health and Disease, 1442
- 10.1038/clpt.2012.159 · DOI
- 10.4088/JCP.11096su1c.03 · DOI
- MacDonald L, 2009, Food and therapeutic product interactions: a therapeutic perspective, J Pharm Pharm Sci, 12, 367, 10.18433/J30P4C · DOI
- 10.1016/j.pharmthera.2012.08.001 · DOI
- 10.1159/000331519 · DOI
- 10.1007/s10620-011-1589-y · DOI
- 10.2337/dc12-0980 · DOI
- 10.1007/s11894-010-0141-0 · DOI · Paper page
- 10.1038/ajg.2009.45 · DOI
- 10.1016/j.amjopharm.2010.02.003 · DOI
- 10.1212/WNL.58.9.1348 · DOI · Paper page
- Feldkamp J, 2000, Long‐term anticonvulsant therapy leads to low bone mineral density—evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast‐like cells, Exp Clin Endocrinol Diabetes, 108, 37
- 10.1111/j.1538-7836.2008.03003.x · DOI
- 10.1038/tpj.2011.4 · DOI
- Chan L‐N, Modern Nutrition in Health and Disease, 1539
- 10.1021/bi700527j · DOI
- 10.1111/j.1538-7836.2005.01419.x · DOI · Paper page
- U.S. Food and Drug Administration (FDA), 2002, Guidance for Industry: Food‐effect Bioavailability and Fed Equivalence Studies
- 10.1097/MPG.0b013e3181eb5ad6 · DOI
- 10.1111/j.2042-7158.2012.01505.x · DOI
- 10.1007/s00424-003-1192-y · DOI · Paper page
- 10.1007/s11095-009-9924-0 · DOI · Paper page
- Estudante M, Intestinal drug transporters: an overview, Adv Drug Deliv Rev
- 10.1016/j.bcp.2005.09.027 · DOI
- 10.1111/j.1476-5381.2011.01438.x · DOI
- 10.1152/physiol.00027.2010 · DOI
- 10.1111/j.1476-5381.2011.01724.x · DOI · Paper page
- 10.1146/annurev-pharmtox-010510-100556 · DOI · Paper page
- 10.1023/A:1021918104127 · DOI
- 10.1016/j.genhosppsych.2011.12.009 · DOI
- 10.1016/j.braindev.2005.11.005 · DOI
- Moreno FA, 2005, Carnitine levels in valproic acid–treated psychiatric patients: a cross‐sectional study, J Clin Psychiatry, 66, 555, 10.4088/JCP.v66n0502 · DOI
- Okamura M, 2003, Inhibitory effect of zinc on PEPT1‐mediated transport of glycylsarcosine and beta‐lactam antibiotics in human intestinal cell line Caco‐2, Pharm Res, 20, 1389, 10.1023/A:1025797808703 · DOI
- 10.2133/dmpk.23.464 · DOI
- 10.1002/jps.22627 · DOI
- 10.1517/14740338.6.6.695 · DOI
- 10.1016/j.jclinepi.2003.08.015 · DOI
- Sheen E, Adverse effects of long‐term proton pump inhibitor therapy, Dig Dis Sci, 56, 931, 10.1007/s10620-010-1560-3 · DOI · Paper page
- 10.1111/j.1365-2036.2008.03658.x · DOI
- 10.1016/j.bone.2008.03.002 · DOI
- Moro‐Alvarez MJ, 2009, Bone disease induced by phenytoin therapy: clinical and experimental study, Eur Neurol, 62, 219, 10.1159/000229309 · DOI
- 10.1128/AAC.38.9.2101 · DOI
- 10.1093/jac/38.5.871 · DOI
- Mimoz O, 1998, Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients, Intensive Care Med, 24, 1047, 10.1007/s001340050714 · DOI
- 10.1177/014860710002400142 · DOI
- 10.1212/WNL.32.5.570 · DOI
- 10.1592/phco.28.3.308 · DOI
- 10.1016/j.nut.2008.05.015 · DOI
- 10.1177/0884533610385701 · DOI
- 10.1345/aph.19355 · DOI
- Chan L‐N, 2012, To hold (enteral feeding) or not to hold: that is the question; a commentary and tutorial, Pract Gastroenterol, 13
Cited by
Nutritional considerations for healthy aging and reduction in age-related chronic disease
Shlisky, J., Bloom, D. E., Beaudreault, A. R., Tucker, K. L., Keller, H. H., Freund-Levi, Y., Fielding, R. A., Cheng, F. W., Jensen, G. L., Wu, D., et al. (2017) · Advances in Nutrition · doi:10.3945/an.116.013474 · Cited by 462
The Use of Medications and Dietary Supplements by Masters Athletes—A Review
Harnett, J., Climstein, M., Walsh, J., & Gifford, J. (2022) · Current Nutrition Reports · doi:10.1007/s13668-022-00398-0 · Cited by 12
Metadata
- Authors
- Chan, L.
- Venue
- Journal of Parenteral and Enteral Nutrition
- Publisher
- Wiley
- Published
- 2013-05-14
- Volume
- 37
- Issue
- 4
- Pages
- 450-459
- ISSN
- 0148-6071
- 1941-2444
- Cited by
- 62
- References
- 4
- Language
- en
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.